Works by Yamaguchi, Kanji

Results: 85
    1

    Impact of Insufficient Response with an Increase in Tumor Number in Predicting Transcatheter Arterial Chemoembolization Refractoriness for Hepatocellular Carcinoma.

    Published in:
    Digestive Diseases, 2018, v. 36, n. 5, p. 385, doi. 10.1159/000489488
    By:
    • Furuta, Mitsuhiro;
    • Moriguchi, Michihisa;
    • Okuda, Keiichiro;
    • Kataoka, Seita;
    • Mizuno, Naoki;
    • Takemura, Masashi;
    • Taketani, Hiroyoshi;
    • Hara, Tasuku;
    • Seko, Yuya;
    • Umemura, Atsushi;
    • Nishikawa, Taichiro;
    • Yamaguchi, Kanji;
    • Yasui, Koichiroh;
    • Minami, Masahito;
    • Itoh, Yoshito
    Publication type:
    Article
    2

    Clinical significance of cachexia index determined by bioelectrical impedance analysis in patients with gastrointestinal cancer.

    Published in:
    Oncology Letters, 2025, v. 29, n. 3, p. N.PAG, doi. 10.3892/ol.2024.14860
    By:
    • Ohara, Tomoya;
    • Iwai, Naoto;
    • Oka, Kohei;
    • Okabe, Kengo;
    • Sakai, Hiroaki;
    • Tsuji, Toshifumi;
    • Okuda, Takashi;
    • Sakagami, Junichi;
    • Kagawa, Keizo;
    • Doi, Toshifumi;
    • Inoue, Ken;
    • Dohi, Osamu;
    • Yoshida, Naohisa;
    • Yamaguchi, Kanji;
    • Moriguchi, Michihisa;
    • Uchiyama, Kazuhiko;
    • Ishikawa, Takeshi;
    • Takagi, Tomohisa;
    • Konishi, Hideyuki;
    • Itoh, Yoshito
    Publication type:
    Article
    3

    SOX2 enhances cell survival and induces resistance to apoptosis under serum starvation conditions through the AKT/GSK-3β signaling pathway in esophageal squamous cell carcinoma.

    Published in:
    Oncology Letters, 2021, v. 21, n. 4, p. N.PAG, doi. 10.3892/ol.2021.12530
    By:
    • Terasaki, Kei;
    • Gen, Yasuyuki;
    • Iwai, Naoto;
    • Soda, Tomohiro;
    • Kitaichi, Tomoko;
    • Dohi, Osamu;
    • Taketani, Hiroyoshi;
    • Seko, Yuya;
    • Umemura, Atsushi;
    • Nishikawa, Taichiro;
    • Yamaguchi, Kanji;
    • Moriguchi, Michihisa;
    • Konishi, Hideyuki;
    • Naito, Yuji;
    • Itoh, Yoshito;
    • Yasui, Kohichiroh
    Publication type:
    Article
    4

    Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease.

    Published in:
    Journal of Gastroenterology, 2015, v. 50, n. 9, p. 996, doi. 10.1007/s00535-015-1039-2
    By:
    • Sumida, Yoshio;
    • Kanemasa, Kazuyuki;
    • Imai, Shunsuke;
    • Mori, Kojiro;
    • Tanaka, Saiyu;
    • Shimokobe, Hideto;
    • Kitamura, Yoko;
    • Fukumoto, Kohei;
    • Kakutani, Akira;
    • Ohno, Tomoyuki;
    • Taketani, Hiroyoshi;
    • Seko, Yuya;
    • Ishiba, Hiroshi;
    • Hara, Tasuku;
    • Okajima, Akira;
    • Yamaguchi, Kanji;
    • Moriguchi, Michihisa;
    • Mitsuyoshi, Hironori;
    • Yasui, Kohichiroh;
    • Minami, Masahito
    Publication type:
    Article
    5
    6
    7

    A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.

    Published in:
    Journal of Gastroenterology, 2011, v. 46, n. 2, p. 257, doi. 10.1007/s00535-010-0305-6
    By:
    • Sumida, Yoshio;
    • Yoneda, Masato;
    • Hyogo, Hideyuki;
    • Yamaguchi, Kanji;
    • Ono, Masafumi;
    • Fujii, Hideki;
    • Eguchi, Yuichiro;
    • Suzuki, Yasuaki;
    • Imai, Shunsuke;
    • Kanemasa, Kazuyuki;
    • Fujita, Koji;
    • Chayama, Kazuaki;
    • Yasui, Kohichiroh;
    • Saibara, Toshiji;
    • Kawada, Norifumi;
    • Fujimoto, Kazuma;
    • Kohgo, Yutaka;
    • Okanoue, Takeshi
    Publication type:
    Article
    8

    Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease.

    Published in:
    Journal of Gastroenterology, 2011, v. 46, n. 1, p. 101, doi. 10.1007/s00535-010-0291-8
    By:
    • Park, Hyohun;
    • Shima, Toshihide;
    • Yamaguchi, Kanji;
    • Mitsuyoshi, Hironori;
    • Minami, Masahito;
    • Yasui, Kohichiroh;
    • Itoh, Yoshito;
    • Yoshikawa, Toshikazu;
    • Fukui, Michiaki;
    • Hasegawa, Goji;
    • Nakamura, Naoto;
    • Ohta, Mitsuhiro;
    • Obayashi, Hiroshi;
    • Okanoue, Takeshi
    Publication type:
    Article
    9

    Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease.

    Published in:
    Journal of Gastroenterology, 2010, v. 45, n. 4, p. 426, doi. 10.1007/s00535-009-0154-3
    By:
    • Park, Hyohun;
    • Ishigami, Akihito;
    • Shima, Toshihide;
    • Mizuno, Masayuki;
    • Maruyama, Naoki;
    • Yamaguchi, Kanji;
    • Mitsuyoshi, Hironori;
    • Minami, Masahito;
    • Yasui, Kohichiroh;
    • Itoh, Yoshito;
    • Yoshikawa, Toshikazu;
    • Fukui, Michiaki;
    • Hasegawa, Goji;
    • Nakamura, Naoto;
    • Ohta, Mitsuhiro;
    • Obayashi, Hiroshi;
    • Okanoue, Takeshi
    Publication type:
    Article
    10
    11
    12

    Loss of KAP3 decreases intercellular adhesion and impairs intracellular transport of laminin in signet ring cell carcinoma of the stomach.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08904-8
    By:
    • Soda, Tomohiro;
    • Gen, Yasuyuki;
    • Terasaki, Kei;
    • Iwai, Naoto;
    • Kitaichi, Tomoko;
    • Dohi, Osamu;
    • Taketani, Hiroyoshi;
    • Seko, Yuya;
    • Umemura, Atsushi;
    • Nishikawa, Taichiro;
    • Yamaguchi, Kanji;
    • Moriguchi, Michihisa;
    • Konishi, Hideyuki;
    • Naito, Yuji;
    • Itoh, Yoshito;
    • Yasui, Kohichiroh
    Publication type:
    Article
    13
    14
    15

    Impact of fibrosis on liver‐related event incidence in nonalcoholic fatty liver disease: A multicenter observational study.

    Published in:
    Hepatology Research, 2023, v. 53, n. 12, p. 1169, doi. 10.1111/hepr.13950
    By:
    • Chayama, Kazuaki;
    • Hiramatsu, Akira;
    • Shima, Toshihide;
    • Itoh, Yoshito;
    • Yamaguchi, Kanji;
    • Nakajima, Tomoaki;
    • Hoshikawa, Kyoko;
    • Kawamura, Yusuke;
    • Akuta, Norio;
    • Ito, Kiyoaki;
    • Kawanaka, Miwa;
    • Sakamoto, Michiie;
    • Harada, Kenichi;
    • Goto, Yoshihito;
    • Nakayama, Takeo;
    • Kumada, Hiromitsu;
    • Okanoue, Takeshi
    Publication type:
    Article
    16

    Validation of the utility of Agile scores to identify advanced fibrosis and cirrhosis in Japanese patients with nonalcoholic fatty liver disease.

    Published in:
    Hepatology Research, 2023, v. 53, n. 6, p. 489, doi. 10.1111/hepr.13890
    By:
    • Oeda, Satoshi;
    • Seko, Yuya;
    • Hayashi, Hideki;
    • Arai, Taeang;
    • Iwaki, Michihiro;
    • Yoneda, Masato;
    • Shima, Toshihide;
    • Notsumata, Kazuo;
    • Ikegami, Tadashi;
    • Fujii, Hideki;
    • Toyoda, Hidenori;
    • Miura, Kouichi;
    • Morishita, Asahiro;
    • Kawata, Kazuhito;
    • Tomita, Kengo;
    • Kawanaka, Miwa;
    • Isoda, Hiroshi;
    • Yamaguchi, Kanji;
    • Fukushima, Hideaki;
    • Kamada, Yoshihiro
    Publication type:
    Article
    17

    Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis‐related fibrosis: Multicenter study.

    Published in:
    Hepatology Research, 2023, v. 53, n. 4, p. 312, doi. 10.1111/hepr.13871
    By:
    • Seko, Yuya;
    • Takahashi, Hirokazu;
    • Toyoda, Hidenori;
    • Hayashi, Hideki;
    • Yamaguchi, Kanji;
    • Iwaki, Michihiro;
    • Yoneda, Masato;
    • Arai, Taeang;
    • Shima, Toshihide;
    • Fujii, Hideki;
    • Morishita, Asahiro;
    • Kawata, Kazuhito;
    • Tomita, Kengo;
    • Kawanaka, Miwa;
    • Yoshida, Yuichi;
    • Ikegami, Tadashi;
    • Notsumata, Kazuo;
    • Oeda, Satoshi;
    • Kamada, Yoshihiro;
    • Sumida, Yoshio
    Publication type:
    Article
    18
    19
    20
    21
    22
    23

    Serum soluble sialic acid‐binding immunoglobulin‐like lectin‐7 concentration as an indicator of liver macrophage activation and advanced fibrosis in patients with non‐alcoholic fatty liver disease.

    Published in:
    Hepatology Research, 2020, v. 50, n. 4, p. 466, doi. 10.1111/hepr.13464
    By:
    • Sakamoto, Yuzuru;
    • Yoshio, Sachiyo;
    • Doi, Hiroyoshi;
    • Kawai, Hironari;
    • Shimagaki, Tomonari;
    • Mori, Taizo;
    • Matsuda, Michitaka;
    • Aoki, Yoshihiko;
    • Osawa, Yosuke;
    • Yoshida, Yuji;
    • Arai, Taeang;
    • Itokawa, Norio;
    • Ito, Takanori;
    • Seko, Yuya;
    • Yamaguchi, Kanji;
    • Itoh, Yoshihito;
    • Mise, Yoshihiro;
    • Saiura, Akio;
    • Taketomi, Akinobu;
    • Kanto, Tatsuya
    Publication type:
    Article
    24
    25
    26
    27

    Hepatic nucleotide binding oligomerization domain -like receptors pyrin domain-containing 3 inflammasomes are associated with the histologic severity of non-alcoholic fatty liver disease.

    Published in:
    Hepatology Research, 2017, v. 47, n. 13, p. 1459, doi. 10.1111/hepr.12883
    By:
    • Mitsuyoshi, Hironori;
    • Yasui, Kohichiroh;
    • Hara, Tasuku;
    • Taketani, Hiroyoshi;
    • Ishiba, Hiroshi;
    • Okajima, Akira;
    • Seko, Yuya;
    • Umemura, Atsushi;
    • Nishikawa, Taichiro;
    • Yamaguchi, Kanji;
    • Moriguchi, Michihisa;
    • Minami, Masahito;
    • Itoh, Yoshito
    Publication type:
    Article
    28

    Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression.

    Published in:
    Hepatology Research, 2017, v. 47, n. 11, p. 1083, doi. 10.1111/hepr.12840
    By:
    • Seko, Yuya;
    • Sumida, Yoshio;
    • Tanaka, Saiyu;
    • Mori, Kojiroh;
    • Taketani, Hiroyoshi;
    • Ishiba, Hiroshi;
    • Hara, Tasuku;
    • Okajima, Akira;
    • Umemura, Atsushi;
    • Nishikawa, Taichiro;
    • Yamaguchi, Kanji;
    • Moriguchi, Michihisa;
    • Kanemasa, Kazuyuki;
    • Yasui, Kohichiroh;
    • Imai, Shunsuke;
    • Shimada, Keiji;
    • Itoh, Yoshito
    Publication type:
    Article
    29

    Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus.

    Published in:
    Hepatology Research, 2017, v. 47, n. 11, p. 1206, doi. 10.1111/hepr.12837
    By:
    • Seko, Yuya;
    • Sumida, Yoshio;
    • Tanaka, Saiyu;
    • Mori, Kojiroh;
    • Taketani, Hiroyoshi;
    • Ishiba, Hiroshi;
    • Hara, Tasuku;
    • Okajima, Akira;
    • Umemura, Atsushi;
    • Nishikawa, Taichiro;
    • Yamaguchi, Kanji;
    • Moriguchi, Michihisa;
    • Kanemasa, Kazuyuki;
    • Yasui, Kohichiroh;
    • Imai, Shunsuke;
    • Shimada, Keiji;
    • Itoh, Yoshito
    Publication type:
    Article
    30

    Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus.

    Published in:
    Hepatology Research, 2017, v. 47, n. 10, p. 1072, doi. 10.1111/hepr.12834
    By:
    • Seko, Yuya;
    • Sumida, Yoshio;
    • Tanaka, Saiyu;
    • Mori, Kojiroh;
    • Taketani, Hiroyoshi;
    • Ishiba, Hiroshi;
    • Hara, Tasuku;
    • Okajima, Akira;
    • Umemura, Atsushi;
    • Nishikawa, Taichiro;
    • Yamaguchi, Kanji;
    • Moriguchi, Michihisa;
    • Kanemasa, Kazuyuki;
    • Yasui, Kohichiroh;
    • Imai, Shunsuke;
    • Shimada, Keiji;
    • Itoh, Yoshito
    Publication type:
    Article
    31
    32

    Association of coronary artery calcification with liver fibrosis in Japanese patients with non-alcoholic fatty liver disease.

    Published in:
    Hepatology Research, 2016, v. 46, n. 11, p. 1107, doi. 10.1111/hepr.12665
    By:
    • Ishiba, Hiroshi;
    • Sumida, Yoshio;
    • Kataoka, Seita;
    • Kuroda, Masaaki;
    • Akabame, Satoshi;
    • Tomiyasu, Kiichiro;
    • Tanaka, Muhei;
    • Arai, Masahiro;
    • Taketani, Hiroyoshi;
    • Seko, Yuya;
    • Okajima, Akira;
    • Hara, Tasuku;
    • Umemura, Atsushi;
    • Nishikawa, Taichiro;
    • Yamaguchi, Kanji;
    • Moriguchi, Michihisa;
    • Mitsuyoshi, Hironori;
    • Yasui, Kohichiroh;
    • Itoh, Yoshito
    Publication type:
    Article
    33
    34
    35
    36

    Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease.

    Published in:
    Hepatology Research, 2015, v. 45, n. 7, p. 771, doi. 10.1111/hepr.12408
    By:
    • Sumida, Yoshio;
    • Yonei, Yoshikazu;
    • Tanaka, Saiyu;
    • Mori, Kojiroh;
    • Kanemasa, Kazuyuki;
    • Imai, Shunsuke;
    • Taketani, Hiroyoshi;
    • Hara, Tasuku;
    • Seko, Yuya;
    • Ishiba, Hiroshi;
    • Okajima, Akira;
    • Yamaguchi, Kanji;
    • Moriguchi, Michihisa;
    • Mitsuyoshi, Hironori;
    • Yasui, Kohichiroh;
    • Minami, Masahito;
    • Itoh, Yoshito
    Publication type:
    Article
    37

    Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2014, v. 44, n. 13, p. 1329, doi. 10.1111/hepr.12308
    By:
    • Jo, Masayasu;
    • Yasui, Kohichiroh;
    • Kirishima, Toshihiko;
    • Shima, Toshihide;
    • Niimi, Toshihisa;
    • Katayama, Takayuki;
    • Mori, Takahiro;
    • Funaki, Jun;
    • Sumida, Yoshio;
    • Fujii, Hideki;
    • Takami, Shiro;
    • Kimura, Hiroyuki;
    • Mitsumoto, Yasuhide;
    • Minami, Masahito;
    • Yamaguchi, Kanji;
    • Yoshinami, Naomi;
    • Mizuno, Masayuki;
    • Sendo, Rei;
    • Tanaka, Saiyu;
    • Shintani, Hiroyuki
    Publication type:
    Article
    38

    Prediction of a favorable clinical course in hepatitis C virus carriers with persistently normal serum alanine aminotransferase levels: A long-term follow-up study.

    Published in:
    Hepatology Research, 2013, v. 43, n. 5, p. 557, doi. 10.1111/j.1872-034X.2012.01091.x
    By:
    • Nishimura, Takeshi;
    • Yamaguchi, Kanji;
    • Fujii, Hideki;
    • Okada, Yorihisa;
    • Yokomizo, Chihiro;
    • Niimi, Toshihisa;
    • Sumida, Yoshio;
    • Yasui, Kohichiroh;
    • Mitsuyoshi, Hironori;
    • Minami, Masahito;
    • Umemura, Atsushi;
    • Shima, Toshihide;
    • Okanoue, Takeshi;
    • Itoh, Yoshito
    Publication type:
    Article
    39

    Treatment extension may benefit female genotype 1 chronic hepatitis C patients with complete early virological response to peginterferon-alpha-2b and ribavirin combination therapy.

    Published in:
    Hepatology Research, 2012, v. 42, n. 10, p. 966, doi. 10.1111/j.1872-034X.2012.01016.x
    By:
    • Nishimura, Takeshi;
    • Yamaguchi, Kanji;
    • Hashimoto, Hiroaki;
    • Niimi, Toshihisa;
    • Yokomizo, Chihiro;
    • Fujii, Hideki;
    • Minami, Masahito;
    • Sakamoto, Masafumi;
    • Ohnish, Naoki;
    • Nagao, Yasuyuki;
    • Okita, Mika;
    • Umemura, Atsushi;
    • Shima, Toshihide;
    • Okanoue, Takeshi;
    • Itoh, Yoshito
    Publication type:
    Article
    40

    Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapy.

    Published in:
    Hepatology Research, 2011, v. 41, n. 12, p. 1145, doi. 10.1111/j.1872-034X.2011.00886.x
    By:
    • Itoh, Yoshito;
    • Nishimura, Takeshi;
    • Yamaguchi, Kanji;
    • Yokomizo, Chihiro;
    • Fujii, Hideki;
    • Minami, Masahito;
    • Nagao, Yasuyuki;
    • Sumida, Yoshio;
    • Hashimoto, Hiroaki;
    • Umemura, Atsushi;
    • Shima, Toshihide;
    • Okanoue, Takeshi;
    • Yoshikawa, Toshikazu
    Publication type:
    Article
    41

    Simple formula to predict response to peginterferon alpha2b and ribavirin combination therapy in genotype 1 chronic hepatitis C patients with high viral loads.

    Published in:
    Hepatology Research, 2011, v. 41, n. 2, p. 126, doi. 10.1111/j.1872-034X.2010.00750.x
    By:
    • Itoh, Yoshito;
    • Nishimura, Takeshi;
    • Hashimoto, Hiroaki;
    • Yamaguchi, Kanji;
    • Niimi, Toshihisa;
    • Yokomizo, Chihiro;
    • Fujii, Hideki;
    • Minami, Masahito;
    • Yasui, Kohichiroh;
    • Mitsuyoshi, Hironori;
    • Okanoue, Takeshi;
    • Takehara, Tetsuo;
    • Hiasa, Yoichi;
    • Onji, Morikazu;
    • Yoshikawa, Toshikazu
    Publication type:
    Article
    42

    Lower circulating levels of dehydroepiandrosterone, independent of insulin resistance, is an important determinant of severity of non-alcoholic steatohepatitis in Japanese patients.

    Published in:
    Hepatology Research, 2010, v. 40, n. 9, p. 901, doi. 10.1111/j.1872-034X.2010.00704.x
    By:
    • Sumida, Yoshio;
    • Yonei, Yoshikazu;
    • Kanemasa, Kazuyuki;
    • Hara, Tasuku;
    • Inada, Yutaka;
    • Sakai, Kyoko;
    • Imai, Shunsuke;
    • Hibino, Sawako;
    • Yamaguchi, Kanji;
    • Mitsuyoshi, Hironori;
    • Yasui, Kohichiroh;
    • Minami, Masahito;
    • Itoh, Yoshito;
    • Naito, Yuji;
    • Yoshikawa, Toshikazu;
    • Okanoue, Takeshi
    Publication type:
    Article
    43
    44
    45
    46
    47

    EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma.

    Published in:
    Cancer Science, 2015, v. 106, n. 7, p. 929, doi. 10.1111/cas.12694
    By:
    • Yasui, Kohichiroh;
    • Konishi, Chika;
    • Gen, Yasuyuki;
    • Endo, Mio;
    • Dohi, Osamu;
    • Tomie, Akira;
    • Kitaichi, Tomoko;
    • Yamada, Nobuhisa;
    • Iwai, Naoto;
    • Nishikawa, Taichiro;
    • Yamaguchi, Kanji;
    • Moriguchi, Michihisa;
    • Sumida, Yoshio;
    • Mitsuyoshi, Hironori;
    • Tanaka, Shinji;
    • Arii, Shigeki;
    • Itoh, Yoshito
    Publication type:
    Article
    48
    49

    Safety/efficacy of atezolizumab + bevacizumab during anti‐platelet/anticoagulation therapy in unresectable hepatocellular carcinoma.

    Published in:
    Liver International, 2024, v. 44, n. 8, p. 1751, doi. 10.1111/liv.15918
    By:
    • Moriguchi, Michihisa;
    • Okuda, Keiichiro;
    • Horiguchi, Go;
    • Kataoka, Seita;
    • Seko, Yuya;
    • Yamaguchi, Kanji;
    • Nishimura, Takeshi;
    • Fujii, Hideki;
    • Mitsumoto, Yasuhide;
    • Miyagawa, Masami;
    • Kirishima, Toshihiko;
    • Okishio, Shinya;
    • Hara, Tasuku;
    • Ishikawa, Hiroki;
    • Nagao, Yasuyuki;
    • Jo, Masayasu;
    • Ishii, Michiaki;
    • Tanaka, Saiyu;
    • Yamauchi, Norihito;
    • Mitsuyoshi, Hironori
    Publication type:
    Article
    50

    The greater impact of PNPLA3 polymorphism on liver‐related events in Japanese non‐alcoholic fatty liver disease patients: A multicentre cohort study.

    Published in:
    Liver International, 2023, v. 43, n. 10, p. 2210, doi. 10.1111/liv.15678
    By:
    • Seko, Yuya;
    • Yamaguchi, Kanji;
    • Shima, Toshihide;
    • Iwaki, Michihiro;
    • Takahashi, Hirokazu;
    • Kawanaka, Miwa;
    • Tanaka, Saiyu;
    • Mitsumoto, Yasuhide;
    • Yoneda, Masato;
    • Nakajima, Atsushi;
    • Fjellström, Ola;
    • Blau, Jenny E.;
    • Carlsson, Björn;
    • Okanoue, Takeshi;
    • Itoh, Yoshito
    Publication type:
    Article